The effect of a febrile state on theophylline clearance in the asthmatic acute phase was quantitatively investigated in 71 Japanese pediatric patients (42 males and 29 females) aged 2 -< 7 years old. Theophylline clearance from each patient was estimated from the plasma steady-state theophylline concentration, which was retrospectively collected during constant-rate infusion of aminophylline. Theophylline clearances were grouped by the presence of a febrile state, and then these were compared in the same gender groups. In male pediatric patients, theophylline clearance during the febrile state was approximately 71％ (P < 0.001) of that during the afebrile state in the asthmatic acute phase. Similarly, in female pediatric patients, it was 85％ (P < 0.05) of that during the afebrile state in the asthmatic acute phase. Our findings suggest that the dose of theophylline in Japanese infants should be reduced during a febrile state in the asthmatic acute phase. However, we found some patients whose theophylline clearance in the asthmatic acute phase with fever was more than 50％ lower compared with the theophylline clearance in the asthmatic assumed-remission phase without fever. Therefore, as for the degree of dose reduction during a febrile state from the asthmatic remission phase, the effects of both febrile state and asthmatic acute phase should be simultaneously considered. We propose that the initial dose of theophylline during a febrile state in the asthmatic acute phase should be reduced by half of the dose in the asthmatic remission phase without fever, similarly to the recommendation of the American Academy of Pediatrics.
Introduction
Theophylline is used as an additional treatment drug for children in the asthmatic acute phase, [1] [2] [3] although the prescription frequency of this drug for children has declined because of concerns about serious adverse effects.
4) Therapeutic and toxic effects of theophylline are related to its plasma concentration, [5] [6] [7] and the clearance of theophylline varies with numerous factors, such as age, gender, concurrent drugs and complicating diseases. 4, 5, 7, 8) An acute febrile state in children may alter theophylline clearance and can lead to toxic results due to its high plasma level. 9-11) Chang et al reported that acute respiratory viral illness with fever reduced theophylline elimination in six children with chronic asthma.
9)
Kraemer et al reported that eleven children with febrile illness, who were previously controlled with a stable theophylline dose, developed theophylline toxicity during an in uenza B outbreak. 10) However, Muslow et al reported the lack of an effect of respiratory syncytial virus on theophylline disposition in children without sustained fever. 12) Therefore, the American Academy of Pediatrics describes that fever is considered to be a more practical clinical indication than a specific etiologic agent for reducing the theophylline dose, and recommends that the dosage should be reduced by half in chil-
dren receiving chronic theophylline therapy who are febrile for more than 24 hours. 13) However, it is unclear whether theophylline clearance is affected quantitatively equally by a febrile state in all children without regard to race, age, and/or gender. 7, 8, 14) In regard to Japanese children, Toba et al reported that the theophylline clearance was reduced by 25％ on average in children with febrile infections aged 1 to 13.5 years. Eligible theophylline clearances were divided by the presence of a febrile state, and then these were studied. A febrile state was con rmed by a body temperature of more than 38°C measured two times or more with an interval of 3 hours or more, or a body temperature of more than 38°C
Patient data
and C-reactive protein of more than 0.5 mg/dL, within 24 hours before estimating. These de nitions of a febrile state were based on a report by 3.9 ± 1.0 3.6 ± 1.1 3.7 ± 1.7 3.7 ± 1.2 3.8 ± 1.4 3.7 ± 1.2 Weight (kg) 1) 16.1 ± 2.2 15.1 ± 3.5 14.7 ± 3.9 14.3 ± 1.7 15.4 ± 3.1 14.8 ± 3.0 Duration of hospital stay (d) 1) 5.9 ± 1.4
6.3 ± 1.9 7.1 ± 2.8 6.6 ± 2.5 6.5 ± 2.2 6.4 ± 2.1 Infusion rate of theophylline (mg/h/kg) 
Estimation of theophylline clearance
The theophylline clearance (mL/h/kg) of each patient was calculated using the following formula: clearance = 10 3 × R/Css, where R is the con-R/Css, where R is the con-R/Css, where R is the con- showed a similar value regardless of gender. With regard to the physiologic characteristics of the patients, insigni cant differences were observed except for the concentrations of theophylline among the male and total gender groups ( Table 1) .
Comparison and statistical analysis
As for the intra-individual effect of the febrile state, in four cases (patient No 4, 6, 8, 12) , the theophylline clearances during a febrile state decreased by nearly 50％ or more compared to the theophylline clearances during an afebrile state estimated at more than 60 hours after the initiation of aminophylline infusion ( Table 2) . Statistical analysis was not performed so that we could not rule out the effects of the age-dependent and dose-dependent kinetics of theophylline due to the variation of age and/or administering rate.
Discussion
In this study, we have shown a signi cant effect of a febrile state on theophylline clearance in the asthmatic acute phase in Japanese children aged 2 - Theophylline clearance varies with physiologic, pathogenic, and drug-related factors. Therefore, when the effect of a febrile state on theophylline clearance is investigated, these effects on theophylline clearance should be considered. We excluded the data of patients who had complications and/or used drugs reported to affect theophylline clearance, other than in a febrile state. Treatments with prednisolone, oxygen supply, or terbutaline were reported to have no effect on theophylline clearance in our previous study.
8)
However, we could not identify infectious pathogens that could trigger a fever and the reduction of theophylline clearance because of the lack of data proved by seroconversion or cultivation. Re- gardless of the type of pathogen that might be related to the degree of the effect on theophylline clearance, the American Academy of Pediatrics described that an acute febrile response per se might be more important in reducing drug metabolism than a speci c etiologic agent, as the clearance of antipyrine was reduced in the presence of etiocholanolone -induced noninfectious fever. 13, 24) The mechanism of reduction of theophylline clearance associated with a febrile state remains to be elucidated, although it has been reported that the administration of external agents such as endotoxin, in uenza vaccine, and interferon also reduced drug metabolism. In conclusion, we propose that the initial dose of theophylline in the asthmatic acute phase with fever should be reduced by half of the dose in the asthmatic remission phase without fever. Thereafter, the dose of theophylline should be adjusted appropriately based on the therapeutic drug monitoring. In addition, more attention for dose-adjustment and therapeutic drug management of theophylline would be required in boys than in girls and in children with high theophylline clearance than in those with low theophylline clearance.
